Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study

BACKGROUND: Sodium-glucose cotransporter-2 inhibitors reduce blood pressure (BP) and renal and cardiovascular events in patients with type 2 diabetes through not fully elucidated mechanisms. Aim of this study was to investigate whether dapagliflozin is able to acutely modify systemic and renal vascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Solini, Anna, Giannini, Livia, Seghieri, Marta, Vitolo, Edoardo, Taddei, Stefano, Ghiadoni, Lorenzo, Bruno, Rosa Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654086/
https://www.ncbi.nlm.nih.gov/pubmed/29061124
http://dx.doi.org/10.1186/s12933-017-0621-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654086/
https://www.ncbi.nlm.nih.gov/pubmed/29061124
http://dx.doi.org/10.1186/s12933-017-0621-8

Ejemplares similares